This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Accidents / James Harrison, 'Golden Arm' Donor, Dies
Accidents death

James Harrison, 'Golden Arm' Donor, Dies

Analysis based on 30 articles · First reported Mar 02, 2025 · Last updated Mar 04, 2025

Sentiment
0
Attention
1
Articles
30
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

This event has no direct financial market impact. It is a humanitarian story about James Harrison's life and legacy, with some mention of ongoing medical research by WEHI and Australian Red Cross Lifeblood.

healthcare biotechnology
Event Summary

James Harrison, known as the 'man with the golden arm,' has died at the age of 88. He was an Australian blood plasma donor whose rare Anti-D antibody saved the lives of over 2.4 million babies by preventing haemolytic disease of the foetus and newborn (HDFN). James Harrison began donating at 18 in 1954, after receiving blood transfusions himself, and continued for over six decades, making 1,173 donations before retiring in 2018. His daughter, Tracey Mellowship, was also an Anti-D recipient. Stephen Cornelissen, CEO of Australian Red Cross Lifeblood, praised James Harrison's generosity. The WEHI and Lifeblood are now working to grow James Harrison's antibody in a laboratory to continue his life-saving work globally.

Key Actions
100 James Harrison died
90 James Harrison donated plasma
70 WEHI grew antibody
Entities Involved
per
James Harrison
James Harrison was a prolific blood plasma donor whose rare Anti-D antibody saved millions of babies. His death marks the end of an era of direct donations, but his legacy continues through laboratory research.
Importance 100.0 Sentiment 0.0
ngo
Australian Red Cross
Australian Red Cross, through its Lifeblood division, managed James Harrison's donations and is involved in research to continue his legacy.
Importance 70.0 Sentiment 0.0
oth
WEHI
WEHI is collaborating with Lifeblood to grow James Harrison's antibody in a laboratory, aiming to prevent haemolytic disease of the foetus and newborn globally.
Importance 50.0 Sentiment 0.0
per
Stephen Cornelissen
Stephen Cornelissen, CEO of Lifeblood, praised James Harrison's contributions and expressed gratitude on behalf of the Australian community.
Importance 30.0 Sentiment 0.0
per
Tracey Mellowship
Tracey Mellowship, James Harrison's daughter and an Anti-D recipient, paid tribute to her father's humanitarian work and highlighted the personal impact of his donations.
Importance 20.0 Sentiment 0.0
cnt
Australia
Importance 0.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.